Temporary authorisation granted for a cohort of patients with the same condition
The Cohort ATU was an ANSM procedure that granted a group of patients with the same condition access to a medicine before marketing authorisation. It included a data collection protocol to assess the benefit-risk balance.
This system was replaced in 2021 by the Early Access Authorisation (AAP), which now regulates large-scale early access to innovative medicines in France.
